This
paper introduces the concept of “Drawing-PADs”
(Drawing paper-based microfluidic analytical devices) allowing to
intuitively evaluate the urinary albumin (Alb) index, a clinically
important parameter used for the early detection of renal deficiencies
related to diabetes, among others. To enable regular monitoring of
the Alb index, a simple examination method suitable for self-diagnosis
is highly desirable. The Drawing-PADs rely on the simultaneous naked
eye detection of Alb and creatinine (Cre) on a single device according
to the distance-based microfluidic PAD (μPAD) approach. The
Alb index is visualized by simply drawing a straight line connecting
the top of two color-changed assay channel sections (Alb and Cre channels),
followed by visually confirming the position of the intercept of the
drawn straight line. The semiquantitative Alb index evaluation performed
with Drawing-PADs does not require any equipment such as a camera,
software, or a color reference chart. The obtained results are independent
of the sample volume and are not influenced by changes in the absolute
Alb and Cre concentrations caused by urine excretion variations, making
spot urine assays possible. Classification of Alb index values according
to clinically relevant criteria (normoalbuminuria, microalbuminuria,
and macroalbuminuria) is readily achieved within 15 min and has been
validated for 15 human urine samples including diabetic patients and
healthy volunteers.
Due to the continuously aging world population, there is a rapidly growing need for self-diagnostic tools that can be used by untrained users at home. Microfluidic paper-based analytical devices (µPADs)...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.